MicroRNA-1297 Inhibits Prostate Cancer Cell Proliferation and Invasion by Targeting the AEG-1/Wnt Signaling Pathway
Overview
Affiliations
MicroRNAs (miRNAs) have been known to be implicated in tumorigenic programs. miR-1297 has been reported to be dysregulated and involved in cancer progression in many types of human cancers. However, the expression level and the role of miR-1297 in prostate cancer remain unclear. Herein, we aimed to investigate the potential role and molecular mechanism of miR-1297 in prostate cancer progression. We found that miR-1297 was significantly downregulated in human prostate cancer specimens as well as in several prostate cancer cell lines. In addition, functional experiments demonstrated that overexpression of miR-1297 remarkably inhibited prostate cancer cell proliferation and invasion whereas miR-1297 suppression significantly promoted prostate cancer cell proliferation and invasion. Bioinformatics analysis showed that the Astrocyte elevated gene-1 (AEG-1), a well-known oncogene, is a predicted target of miR-1297. Dual-luciferase reporter assay showed that miR-1297 was able to directly target the 3'-untranslated region of AEG-1. In addition, RT-qPCR and Western blot analysis showed that miR-1297 regulated the mRNA and protein expression levels of AEG-1. We also showed that miR-1297 was able to regulate the Wnt signaling pathway. Moreover, rescue assays indicated that AEG-1 contributed to miR-1297-endowed effects on cell proliferation and invasion as well as Wnt signaling pathway. Taken together, these findings suggest that miR-1297 inhibits prostate cancer proliferation and invasion by targeting AEG-1, thereby providing novel insight into understanding the pathogenesis of prostate cancer. Thus, miR-1297 may be a novel potential therapeutic candidate to treat prostate cancer.
Bu T, Li L, Tian J Front Pharmacol. 2023; 14:1269233.
PMID: 37829301 PMC: 10565042. DOI: 10.3389/fphar.2023.1269233.
MiR-183-5p promotes migration and invasion of prostate cancer by targeting TET1.
Feng Y, Wang K, Qin M, Zhuang Q, Chen Z BMC Urol. 2023; 23(1):116.
PMID: 37430206 PMC: 10334645. DOI: 10.1186/s12894-023-01286-7.
miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2.
Jiang P, Mao L, Lei X, Luo C, Zhang Y, Zhong X Am J Cancer Res. 2022; 12(7):3464-3478.
PMID: 35968334 PMC: 9360223.
Li X, Liu Q, Wang K, Luo W, Liang T, Yuan S RSC Adv. 2022; 10(3):1498-1506.
PMID: 35494689 PMC: 9048252. DOI: 10.1039/c9ra08693e.
Wnt/β-catenin signal transduction pathway in prostate cancer and associated drug resistance.
Wang C, Chen Q, Xu H Discov Oncol. 2022; 12(1):40.
PMID: 35201496 PMC: 8777554. DOI: 10.1007/s12672-021-00433-6.